PAHC — Phibro Animal Health Share Price
0.000.00%
Last trade - 00:00- $754.99m
- $1.14bn
- $977.89m
- 88
- 55
- 97
- 94
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 12.03 | ||
| PEG Ratio (f) | 0.52 | ||
| EPS Growth (f) | 30.26% | ||
| Dividend Yield (f) | 2.68% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.65 | ||
| Price to Tang. Book | 4.27 | ||
| Price to Free Cashflow | 17.71 | ||
| Price to Sales | 0.71 | ||
| EV to EBITDA | 11.69 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.43% | ||
| Return on Equity | 4.85% | ||
| Operating Margin | 5.87% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 828 | 800.35 | 833.35 | 942.26 | 977.89 | 1,007.91 | 1,175.92 | 3.59% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -23.67 | -38.94 | +66.96 | -8.84 | -25.85 | +24.5 | +30.35 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Phibro Animal Health Corporation is a diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 770 product lines in over 80 countries to approximately 4,000 customers. The Company has three segments. Animal Health segment develops, manufactures and markets about 270 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. Mineral Nutrition segment manufactures and markets approximately 420 formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries, predominantly in the United States.
Directors
- Jack Bendheim CHM (74)
- Damian Finio CFO (51)
- Jonathan Bendheim CEX (44)
- Rob Aukerman CEX (63)
- Larry Miller COO (56)
- Daniel Bendheim EVP (48)
- Thomas Dagger SVP (62)
- Lisa Escudero SVP (59)
- Anthony Andolino VFN (52)
- Gerald Carlson IND (77)
- E. Corcoran IND (73)
- Sam Gejdenson IND (72)
- Mary Malanoski IND (63)
- Carol Wrenn IND (60)
- Last Annual
- June 30th, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- January 27th, 2014
- Public Since
- April 11th, 2014
- No. of Shareholders
- 2
- No. of Employees
- 1,920
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- NASDAQ Global Market
- Shares in Issue
- 40,503,608
- Address
- 300 Frank W. Burr Blvd., TEANECK, 07666
- Web
- https://www.pahc.com/
- Phone
- +1 2013297300
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for PAHC
Phibro Animal Health Corp Annual Shareholders Meeting
Q1 2025 Phibro Animal Health Corp Earnings Release
Similar to PAHC
111
NASDAQ Global Market
ADMA Biologics
NASDAQ Global Market
Alimera Sciences
NASDAQ Global Market
ANI Pharmaceuticals
NASDAQ Global Market
Aquestive Therapeutics
NASDAQ Global Market
FAQ
What is the Phibro Animal Health share price?
As of Today at 16:40 UTC, shares in Phibro Animal Health are trading at $17.64. This share price information is delayed by 15 minutes.
How has the Phibro Animal Health share price performed this year?
Shares in Phibro Animal Health last closed at $17.64 and the price had moved by +28.95% over the past 365 days. In terms of relative price strength the Phibro Animal Health share price has outperformed the S&P500 Index by +2.61% over the past year.
What are the analyst and broker recommendations for Phibro Animal Health?
The overall consensus recommendation for Phibro Animal Health is Sell. You can view the full broker recommendation list by unlocking its StockReport.
What is the Phibro Animal Health dividend yield?
The Phibro Animal Health dividend yield is 2.72% based on the trailing twelve month period.
Does Phibro Animal Health pay a dividend?
Last year, Phibro Animal Health paid a total dividend of $0.48, and it currently has a trailing dividend yield of 2.72%.Looking ahead, the next dividend pay date is 2024-06-26.
When does Phibro Animal Health next pay dividends?
We do not have data on when Phibro Animal Health is to next pay dividends. The historic dividend yield on Phibro Animal Health shares is currently 2.72%.
How do I buy Phibro Animal Health shares?
To buy shares in Phibro Animal Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Phibro Animal Health?
As of the previous close price of $17.64, shares in Phibro Animal Health had a market capitalisation of $714.48m.
Where are Phibro Animal Health shares listed?
Here are the trading details for Phibro Animal Health:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: PAHC
What kind of share is Phibro Animal Health?
Based on an overall assessment of its quality, value and momentum Phibro Animal Health is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Phibro Animal Health share price forecast for 2024?
The analyst consensus target price for shares in Phibro Animal Health is $13.50. That is 23.47% below the last closing price of $17.64.
Analysts covering Phibro Animal Health currently have a consensus Earnings Per Share (EPS) forecast of $1.13 for the next financial year.
What is the trend in the Phibro Animal Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Phibro Animal Health. Over the past six months, its share price has outperformed the S&P500 Index by +37.49%.
As of the last closing price of $17.64, shares in Phibro Animal Health were trading +35.77% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Phibro Animal Health PE Ratio?
The Phibro Animal Health PE ratio based on its reported earnings over the past 12 months is 12.03. The shares last closed at $17.64.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Phibro Animal Health?
Phibro Animal Health's management team is headed by:
- Jack Bendheim - CHM
- Damian Finio - CFO
- Jonathan Bendheim - CEX
- Rob Aukerman - CEX
- Larry Miller - COO
- Daniel Bendheim - EVP
- Thomas Dagger - SVP
- Lisa Escudero - SVP
- Anthony Andolino - VFN
- Gerald Carlson - IND
- E. Corcoran - IND
- Sam Gejdenson - IND
- Mary Malanoski - IND
- Carol Wrenn - IND